Trial Profile
Clinical Trials Insight: 700027251
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 May 2008
Price :
$35
*
At a glance
- Drugs INCB 9471 (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Incyte Corporation
- 30 Apr 2008 Status changed from planning to discontinued.
- 02 Oct 2007 New trial record.